Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:14-16
doi: 10.1161/01.CIR.0000022730.66617.D9
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waktare, J. E.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waktare, J. E.P.
Related Collections
Right arrow Ablation/ICD/surgery
Right arrow Acute coronary syndromes
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Embolic stroke
Right arrow Risk Factors for Stroke
Right arrow Anticoagulants

(Circulation. 2002;106:14.)
© 2002 American Heart Association, Inc.


Cardiology Patient Page

Atrial Fibrillation

Johan E.P. Waktare, MB, ChB, MRCP

From the Cardiology Department, University Hospital Birmingham, Edgebaston, Birmingham, UK.

Correspondence to Dr Johan E.P. Waktare, Cardiology Department, University Hospital Birmingham, Edgebaston, Birmingham, B15 2TH, UK. E-mail jwaktare@blueyonder.co.uk


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

A trial fibrillation (AF) is the most common cardiac arrhythmia and effects nearly 1% of the population. Its prevalence increases with increasing age; it is relatively infrequent in those under 40 years old, but occurs in up to 5% of those over 80 years of age.

Normal Heart Electrical Activity and What Goes Wrong in AF

The heart is essentially a large muscular pump that drives blood around the body. To do this effectively, the heart’s chambers must be precisely controlled electrically (Figure 1). The normal heartbeat begins with the natural pacemaker (the sinoatrial [SA] node) in the top right heart chamber (the right atrium). Activity spreads across the atria, causing them to contract. The contraction of the atria propels extra blood into the ventricles, which are the main pumping chambers. The electrical signal is delayed by about one tenth of a second by a special structure called the atrioventricular (AV) node, and then spreads rapidly across the ventricles to make them contract. Extra filling of the ventricles by the atria is not vital, but does serve to "prime the ventricular pump" and improve overall heart function.


Figure Removed (Available Only in the Full Text)
View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. The atria contain the heart’s natural pacemaker, the SA node, and are the part of the heart affected by atrial fibrillation. The ventricles are the muscular part of the heart that actually pump the blood. They are electrically isolated from the atria, and the only way the electrical signal can reach them is via the AV node.

Normal heart rhythm is termed sinus rhythm. Most people have a resting . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
J. B. Shea and S. F. Sears
A Patient's Guide to Living With Atrial Fibrillation
Circulation, May 20, 2008; 117(20): e340 - e343.
[Full Text] [PDF]


Home page
CirculationHome page
A. Ames and W. G. Stevenson
Catheter Ablation of Atrial Fibrillation
Circulation, April 4, 2006; 113(13): e666 - e668.
[Full Text] [PDF]


Home page
HeartHome page
A Boldt, U Wetzel, J Lauschke, J Weigl, J Gummert, G Hindricks, H Kottkamp, and S Dhein
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease
Heart, April 1, 2004; 90(4): 400 - 405.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Boldt, U. Wetzel, J. Weigl, J. Garbade, J. Lauschke, G. Hindricks, H. Kottkamp, J. F. Gummert, and S. Dhein
Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1785 - 1792.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. Pasic, W. C. Levy, and M. D. Sullivan
Cytokines in Depression and Heart Failure
Psychosom Med, March 1, 2003; 65(2): 181 - 193.
[Abstract] [Full Text] [PDF]